Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Saikosaponin A
2. Saikosaponin B
3. Saikosaponin B1
4. Saikosaponin B3
5. Saikosaponin B4
6. Saikosaponin C
7. Saikosaponin D
8. Saikosaponin K
9. Saikosaponin L
10. Saikosaponins
1. 58316-41-9
2. Saikosaponinb2
3. (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,4r,4ar,6ar,6bs,8r,8as,14ar,14bs)-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
4. Schembl7523565
5. Chembl3792981
6. Chebi:183954
7. Hy-n0248
8. S9303
9. Zinc85643336
10. Akos037514824
11. Ccg-270463
12. Cs-0008279
13. 316s419
14. A869478
15. Q-100669
16. Q63395661
17. (3b,4a,16a)-16,23,28-trihydroxyoleana-11,13(18)-dien-3-yl-6-deoxy-3-o-beta-d-glucopyranosyl-beta-d-galactopyranoside
| Molecular Weight | 781.0 g/mol |
|---|---|
| Molecular Formula | C42H68O13 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 9 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 7 |
| Exact Mass | 780.46599222 g/mol |
| Monoisotopic Mass | 780.46599222 g/mol |
| Topological Polar Surface Area | 219 Ų |
| Heavy Atom Count | 55 |
| Formal Charge | 0 |
| Complexity | 1500 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 19 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
Immunosuppressive Agents
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)
ABOUT THIS PAGE
76
PharmaCompass offers a list of Saikosaponin B2 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Saikosaponin B2 manufacturer or Saikosaponin B2 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Saikosaponin B2 manufacturer or Saikosaponin B2 supplier.
PharmaCompass also assists you with knowing the Saikosaponin B2 API Price utilized in the formulation of products. Saikosaponin B2 API Price is not always fixed or binding as the Saikosaponin B2 Price is obtained through a variety of data sources. The Saikosaponin B2 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Saikosaponin B2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Saikosaponin B2, including repackagers and relabelers. The FDA regulates Saikosaponin B2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Saikosaponin B2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Saikosaponin B2 supplier is an individual or a company that provides Saikosaponin B2 active pharmaceutical ingredient (API) or Saikosaponin B2 finished formulations upon request. The Saikosaponin B2 suppliers may include Saikosaponin B2 API manufacturers, exporters, distributors and traders.
Saikosaponin B2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Saikosaponin B2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Saikosaponin B2 GMP manufacturer or Saikosaponin B2 GMP API supplier for your needs.
A Saikosaponin B2 CoA (Certificate of Analysis) is a formal document that attests to Saikosaponin B2's compliance with Saikosaponin B2 specifications and serves as a tool for batch-level quality control.
Saikosaponin B2 CoA mostly includes findings from lab analyses of a specific batch. For each Saikosaponin B2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Saikosaponin B2 may be tested according to a variety of international standards, such as European Pharmacopoeia (Saikosaponin B2 EP), Saikosaponin B2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Saikosaponin B2 USP).
